Is increased chronological age a contraindication to debulking surgery for elderly patients with advanced ovarian cancer?

被引:1
|
作者
Park, Soo Jin [1 ]
Mun, Jaehee [1 ]
Yim, Ga Won [2 ]
Lee, Maria [1 ]
Chung, Hyun Hoon [1 ]
Kim, Jae Weon [1 ]
Park, Noh Hyun [1 ]
Song, Yong Sang [1 ]
Kim, Hee Seung [1 ]
机构
[1] Seoul Natl Univ, Dept Obstet & Gynecol, Coll Med, 101 Daehak Ro, Seoul 03080, South Korea
[2] Dongguk Univ, Dept Obstet & Gynecol, Coll Med, Goyang, South Korea
关键词
Aged; ovarian neoplasm; postoperative complications; prognosis; surgical procedure; CYTOREDUCTIVE SURGERY; CHEMOTHERAPY; MORBIDITY; COMORBIDITY; TOXICITY; OUTCOMES; RISK;
D O I
10.1080/01443615.2022.2112021
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
We collected data of elderly patients aged 65 years and older who underwent debulking surgery for advanced ovarian cancer in order to explore the impact of old age on surgical outcomes and complications. A total of 120 patients were classified as follows: group 1, 65-69 years (n = 58); group 2, 70-74 years (n = 38); group 3, 75-79 years (n = 17); group 4, >= 80 years (n = 7). There were no differences in most of the characteristics, surgical extent and outcomes, and postoperative complications between the four groups, whereas polypharmacy was more common (6 vs. 5-16; p=.02) and operation time was shorter (median, 194 vs. 285-330 min; p=.02) in group 4. Factors related to frailty rather than age, polypharmacy, preoperative albumin level, estimated blood loss and transfusion increased the risk of postoperative complications. Thus, the impact of old age on surgical extent, outcomes and postoperative complications may be minimal in elderly patients with advanced ovarian cancer. Impact Statement What is already known on this subject? Optimal debulking surgery is a significant factor in improving the prognosis of ovarian cancer but it is not easy to perform such radical surgery on elderly patients in fear of increasing surgical morbidity and mortality. Some studies suggest that underlying comorbidities may be a stronger contributing factor to increasing such risk rather than old age although there is not enough evidence yet. What do the results of this study add? Through this study, we could see that increased age is not the determining cause of increased morbidity and mortality in elderly patients who undergo optimal debulking surgery in ovarian cancer. There are other aspects describing a patient's health status that can predict prognosis better rather than age. What are the implications of these findings for clinical practice and/or further research? Old age need not be a contraindication when performing optimal debulking surgery in elderly patients with advanced ovarian cancer.
引用
下载
收藏
页码:3254 / 3259
页数:6
相关论文
共 50 条
  • [1] INTERVAL DEBULKING SURGERY FOR ADVANCED OVARIAN CANCER IN ELDERLY PATIENTS (≥70 Y): DOES THE AGE MATTER?
    Pinelli, C.
    Morotti, M.
    Casarin, J.
    Tozzi, R.
    Ghezzi, F.
    Alazzam, M.
    Majd, H. Soleymani
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A509 - A509
  • [2] Interval Debulking Surgery for Advanced Ovarian Cancer in Elderly Patients (≥70 y): Does the Age Matter?
    Pinelli, Ciro
    Morotti, Matteo
    Casarin, Jvan
    Tozzi, Roberto
    Ghezzi, Fabio
    Mavroeidis, Vasileios K.
    Alazzam, Moiad
    Majd, Hooman Soleymani
    JOURNAL OF INVESTIGATIVE SURGERY, 2021, 34 (09) : 1023 - 1030
  • [3] Splenectomy as a part of debulking surgery in patients with advanced ovarian cancer
    Derlatka, Pawel
    Grabowska-Derlatka, Laretta
    Sienko, Jacek
    Danska-Bidzinska, Anna
    GINEKOLOGIA POLSKA, 2014, 85 (08) : 605 - 608
  • [4] Is chronological age really not a contraindication to gastrectomy for very elderly patients?
    Yu, Jiong-Jie
    Sun, Li-Yang
    Yang, Tian
    SURGERY TODAY, 2018, 48 (10) : 968 - 969
  • [5] Is chronological age really not a contraindication to gastrectomy for very elderly patients?
    Jiong-Jie Yu
    Li-Yang Sun
    Tian Yang
    Surgery Today, 2018, 48 : 968 - 969
  • [6] Timing of debulking surgery in advanced ovarian cancer
    Vergote, I.
    van Gorp, T.
    Amant, F.
    Leunen, K.
    Neven, P.
    Berteloot, P.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2008, 18 : 11 - 19
  • [7] Primary debulking surgery or neoadjuvant chemotherapy followed by interval debulking surgery for patients with advanced ovarian cancer
    Hong Zheng
    Yu-Nong Gao
    Chinese Journal of Cancer Research, 2012, 24 (04) : 304 - 309
  • [8] Primary debulking surgery or neoadjuvant chemotherapy followed by interval debulking surgery for patients with advanced ovarian cancer
    Zheng, Hong
    Gao, Yu-Nong
    CHINESE JOURNAL OF CANCER RESEARCH, 2012, 24 (04) : 304 - 309
  • [9] PRIMARY DEBULKING SURGERY OR NEOADJUVANT CHEMOTHERAPY FOLLOWED BY INTERVAL DEBULKING SURGERY FOR PATIENTS WITH ADVANCED EPITHELIAL OVARIAN CANCER?
    Mansouri, H.
    Zemni, I.
    Ben Safta, I.
    Achouri, L.
    Ben Hassouna, J.
    Hechiche, M.
    Chargui, R.
    Rahal, K.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A120 - A120
  • [10] Advanced Ovarian Cancer: Primary or Interval Debulking? Five Categories of Patients in View of the Results of Randomized Trials and Tumor Biology: Primary Debulking Surgery and Interval Debulking Surgery for Advanced Ovarian Cancer
    Makar, Amin P.
    Trope, Claes G.
    Tummers, Philippe
    Denys, Hannelore
    Vandecasteele, Katrien
    ONCOLOGIST, 2016, 21 (06): : 745 - 754